Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials

被引：1
|
作者：
Liu, Mei [1 ]
Fang, Huiying [1 ]
Qian, Shengqiang [2 ]
机构：
[1] Chongqing Univ, Chongqing Key Lab Translat Res Canc Metastasis &, Canc Hosp, Chongqing 400030, Peoples R China
[2] Chongqing Hosp Tradit Chinese Med, Dept Urol, Chongqing 400000, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2022年 / 45卷 / 09期
关键词：
D O I：
10.1016/j.asjsur.2022.01.039
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1748 / 1750
页数：3
相关论文
共 50 条
  • [1] Additional adjuvant capecitabine in early breast cancer patients: a meta-analysis of randomized controlled trials
    Zhou, Wenqi
    Cao, Yong
    Gou, Ping
    Zeng, Xiaohua
    Hu, Xiaolei
    Lin, Zhousheng
    Ye, Changsheng
    Chen, Lujia
    Yao, Guangyu
    [J]. FUTURE ONCOLOGY, 2021, 17 (35) : 4993 - 5002
  • [2] Capecitabine in early breast cancer: A meta-analysis of randomized controlled trials
    Natori, A.
    Ethier, J-L
    Amir, E.
    Cescon, D. W.
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Alcantara, M. J. E.
    Ordinario, M. V.
    Li, R. K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1245 - S1246
  • [4] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Ordinario, M. V. C.
    Alcantara, M. J. E.
    Li, R. K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S320 - S320
  • [5] Platinum-based adjuvant therapy was efficient for triple-negative breast cancer: a meta-analysis from randomized controlled trials
    Xie, Kaigang
    Ren, Xuanlei
    Hong, Xiaoming
    Zhu, Shuiyin
    Wang, Dongjie
    Ye, Xiaoming
    Ren, Xiaoting
    [J]. BIOENGINEERED, 2022, 13 (06) : 14827 - 14839
  • [6] Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials
    Li, Zhiyang
    Zheng, Jiehua
    Ji, Zeqi
    Chen, Lingzhi
    Wu, Jinyao
    Zou, Juan
    Liu, Yiyuan
    Lin, Weixun
    Cai, Jiehui
    Chen, Yaokun
    Chen, Yexi
    Lu, Hai
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [7] Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
    Xun, Xueqiong
    Cao, Qinguang
    Hong, Pan
    Rai, Saroj
    Zhou, Yeming
    Liu, Ruikang
    Hu, Huiyong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Li, Yan
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Zhang, Xiaohui
    Shen, Songjie
    Sun, Qiang
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (03) : 533 - 542
  • [9] Adjuvant addition of capecitabine to early-stage triple-negative breast cancer patients receiving standard chemotherapy: a meta-analysis
    Yan Li
    Yidong Zhou
    Feng Mao
    Yan Lin
    Xiaohui Zhang
    Songjie Shen
    Qiang Sun
    [J]. Breast Cancer Research and Treatment, 2020, 179 : 533 - 542
  • [10] Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis
    Bai, Jie
    Yao, Xufeng
    Pu, Yinghong
    Wang, Xiaoyi
    Luo, Xinrong
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
12345